This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Glucose Intolerance
and you are
between 18 and 70
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to determine the effect of feeding frequency on glucose and insulin metabolism and substrate partitioning in impaired glucose tolerant (IGT) men.

Provided treatments

  • : low feeding frequency (3x)
  • : High feeding frequency (14x)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01456754. The sponsor of the trial is Maastricht University Medical Center and it is looking for 11 volunteers for the current phase.
Official trial title:
Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning in Impaired Glucose Tolerant (IGT) Men